Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
IMCIVREE helps reestablish and maintain MC4R pathway function, providing the foundation for effective long-term treatment of obesity due to BBS
Some individuals who achieve meaningful results with medication may eventually decide that surgery offers a more durable solution
GLP-1 receptor agonism is the mechanism semaglutide uses alone
Coverage is expansive
Tirzepatide's dual mechanism may offer superior glycemic and weight outcomes for patients with more severe metabolic dysfunction or inadequate response to single-agent GLP-1 therapy
US$ 20.37
US$ 20.79
US$ 20.44
US$ 22.66
US$ 28.70
US$ 26.03
US$ 26.96
US$ 26.42
